Prostate Cancer Ontology
Center for Systems Biology, Sichuan University West China Hospital, Sichuan China
跳过导航链接。
折叠 前列腺癌前列腺癌
展开 前列腺癌流行病学前列腺癌流行病学
展开 前列腺癌的诊断前列腺癌的诊断
折叠 前列腺癌的治疗前列腺癌的治疗
展开 延期治疗延期治疗
展开 外科手术外科手术
展开 放射疗法放射疗法
展开 冷冻疗法冷冻疗法
展开 激素疗法激素疗法
展开 化疗化疗
展开 去势抵抗性前列腺癌(CRPC)去势抵抗性前列腺癌(CRPC)
展开 转移性前列腺癌转移性前列腺癌
折叠 其他治疗方式其他治疗方式
展开 老年男性前列腺癌的治疗老年男性前列腺癌的治疗
展开 局部前列腺癌除手术和放疗以外的其他初级治疗选择局部前列腺癌除手术和放疗以外的其他初级治疗选择
折叠 局部前列腺癌患者的治疗后生活质量局部前列腺癌患者的治疗后生活质量
展开 根治性目的治疗后仅限PSA复发的治疗根治性目的治疗后仅限PSA复发的治疗
体外放射治疗与低剂量率近距离放射治疗
Preferred Name External-beam radiotherapy and low-dose rate brachytherapy
Definition EBRT and I-125 low-dose rate (LDR) brachytherapy may cause urinary, sexual- and bowel dysfunction. Both methods can result in irritative voiding symptoms, such as urgency, frequency, and urge incontinence, that negatively affect overall urinary function and HRQoL [639]. In the radiotherapy group, urinary incontinence was reported to be at its worst by 2 months after surgery, but the effects of EBRT on urinary symptoms had resolved at 12 months and improved over baseline at 24 months [639]. Patients in the LDR brachytherapy group reported significant detriments in urinary irritation or obstruction and incontinence. At 1-2 years after LDR brachytherapy, incontinence was reported by 4-6% of patients. Eighteen percent of the LDR brachytherapy group and 11% of the EBRT group reported distress from overall urinary symptoms at 1 year.
Synonyms & Abbreviations Complications of high-intensity focused ultrasound
ReferenceCode NA
ReferenceURL NA
PMID NA
Copyright (C) 2022 Institutes for Systems Genetics, Sichuan University West China Hospital. All Rights Reserved.